In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease.

Autor: Mota, Mânlio Tasso de Oliveira, Costa, Vivian Vasconcelos, Sugimoto, Michelle Amantéa, Guimarães, Georgia de Freitas, Queiroz-Junior, Celso Martins, Moreira, Thaiane Pinto, de Sousa, Carla Daiane, Santos, Franciele Martins, Queiroz, Victoria Fulgêncio, Passos, Ingredy, Hubner, Josy, Souza, Danielle Gloria, Weaver, Scott C., Teixeira, Mauro Martins, Nogueira, Maurício Lacerda
Předmět:
Zdroj: Scientific Reports; 3/24/2020, Vol. 10 Issue 1, p1-16, 16p
Abstrakt: Mayaro virus (MAYV) is endemic in South American countries where it is responsible for sporadic outbreaks of acute febrile illness. The hallmark of MAYV infection is a highly debilitating and chronic arthralgia. Although MAYV emergence is a potential threat, there are no specific therapies or licensed vaccine. In this study, we developed a murine model of MAYV infection that emulates many of the most relevant clinical features of the infection in humans and tested a live-attenuated MAYV vaccine candidate (MAYV/IRES). Intraplantar inoculation of a WT strain of MAYV into immunocompetent mice induced persistent hypernociception, transient viral replication in target organs, systemic production of inflammatory cytokines, chemokines and specific humoral IgM and IgG responses. Inoculation of MAYV/IRES in BALB/c mice induced strong specific cellular and humoral responses. Moreover, MAYV/IRES vaccination of immunocompetent and interferon receptor-defective mice resulted in protection from disease induced by the virulent wt MAYV strain. Thus, this study describes a novel model of MAYV infection in immunocompetent mice and highlights the potential role of a live-attenuated MAYV vaccine candidate in host's protection from disease induced by a virulent MAYV strain. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje